Replies to post #187659 on NorthWest Biotherapeutics Inc (NWBO)

[Kypee]

So it looks like NICE does care about the long tail, and if we actually have a resemblance of a long tail with DCVax-L that may help in the long run for approvals. Lets hope the data is there.

[longfellow95]

Here's the actual NICE findings on their Yescarta appraisal.
Interesting read as these always are.

All the cost-effectiveness estimates came out at above £50,000 for each QALY gained. So well beyond the value threshold.

https://www.nice.org.uk/guidance/GID-TA10214/documents/appraisal-consultation-document